TREA

79305894 - BELMONITOR COV-2

Follow

Information

  • Trademark
  • 79305894
  • Serial Number
    79305894
  • Registration Number
    6720755
  • Filing Date
    December 22, 2020
    4 years ago
  • Registration Date
    May 24, 2022
    3 years ago
  • Transaction Date
    September 14, 2022
    2 years ago
  • Status Date
    May 24, 2022
    3 years ago
  • Published for Opposition Date
    February 22, 2022
    3 years ago
  • Location Date
    May 24, 2022
    3 years ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    LOOK, JEFFREY J
  • Attorney Docket Number
    28362-0181
    Attorney Name
    Brian P. Gregg
    Law Office Assigned Location Code
    O30
  • Owners
Information
Mark Drawing Code
3000
Mark Identification
BELMONITOR COV-2
Case File Statements
  • DM0000: The mark consists of the wording "BelMonitor" in stylized letter with "BEL" in dark blue and "MONITOR" in light blue with "COV-2" in white letters inside a light blue rectangle beneath the letters "BEL".
  • GS0051: Reagents for medical use; diagnostic chemical reagents for medical use; clinical medical reagents; clinical diagnostic reagents for medical purposes; enzymes for medical purposes with all of the foregoing for use in testing and diagnosing Sars-Cov-2 exposure; medical preparations and chemicals for pharmaceutical use, namely, for use in the treatment and disagnosis of SARS,COV-2 or Covid-19; pharmaceutical preparations in strip form for the treatment of Covid-19; pharmaceutical preparations for the prevention of disorders of the endocrine system that may be affected by Covid-19; chemical preparations for testing blood for medical purposes to determine Sars-Cov-2 or Covid-19 exposure; chemical preparations for medical purposes, namely, for the treatment of Covid-19; chemico-pharmaceutical preparations for the treatment of Covid-19; pharmaceutical preparations for the prevention of diseases of the metabolic system, in particular, Sars-Cov-2; in-vitro reagents for medical diagnostic purposes to determine exposure to Sars-Cov-2; chemical preparations for pharmaceutical purposes, namely, for treatment of Covid-19; medical diagnostic test strips for testing for Covid-19 viral infection; diagnostic agents for medical use and diagnostic reagents for medical use in testing for Sars-Cov-2 exposure; medicated mouth spray for treating Covid-19 viral infections; pharmaceutical preparations for the prevention of disorders of the metabolic system related to Sars-Cov-2 exposure; pharmaceutical preparations for the treatment of Covid-19 viral infections; chemical preparations for use in DNA analysis for medical purposes related to diagnosing and treating Sars-Cov-2; biological reagents for medical diagnostic use for medical purposes related to diagnosing and treating Sars-Cov-2; diagnostic chemical reagents for medical use related to diagnosing and treating Sars-Cov-2
  • PM0001: BELMONITOR COV-TWO
  • CC0000: The color(s) light blue, dark blue and white is/are claimed as a feature of the mark.
  • GS0101: Genetic testing apparatus for medical purposes for diagnosing exposure to Sars-Cov-2; chromatogram analyzers for medical use; patient monitoring sensors and alarms; chromatographic instruments for medical use; tools for medical diagnostics, namely, medical ultrasound apparatus, spirometers, electromagnetic medical diagnostic imaging apparatus, medical instruments for examining women's reproductive organs, medical instruments for use in performing biopsies; chromatographic apparatus for medical use; physical analyzers for medical use, namely, hematology analyzers for medical diagnostic uses, body composition analyzers for medical purposes, skin moisture analyzers for medical purposes, analyzers for the analysis of body fluids; medical diagnostic saliva pads; immunoadsorption columns for medical diagnostic use; chromatographic columns for medical use; apparatus for blood monitoring for medical use; spittoons for medical purposes; all of the foregoing for use in diagnosing or treating Sars-Cov-2 infections
  • D10000: "COV-2"
Case File Event Statements
  • 9/14/2022 - 2 years ago
    26 - GENERIC MADRID TRANSACTION SENT TO IB Type: XXSS
  • 9/14/2022 - 2 years ago
    25 - GENERIC MADRID TRANSACTION CREATED Type: XXCR
  • 8/24/2022 - 2 years ago
    24 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR
  • 5/24/2022 - 3 years ago
    23 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC
  • 5/24/2022 - 3 years ago
    22 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 2/22/2022 - 3 years ago
    21 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 2/22/2022 - 3 years ago
    20 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 2/20/2022 - 3 years ago
    19 - NOTIFICATION PROCESSED BY IB Type: GPNX
  • 2/2/2022 - 3 years ago
    18 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS
  • 2/2/2022 - 3 years ago
    17 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Type: OP2R
  • 2/2/2022 - 3 years ago
    16 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 1/14/2022 - 3 years ago
    15 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 1/11/2022 - 3 years ago
    14 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 1/10/2022 - 3 years ago
    13 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 1/10/2022 - 3 years ago
    12 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 8/1/2021 - 3 years ago
    11 - REFUSAL PROCESSED BY IB Type: RFNT
  • 7/14/2021 - 3 years ago
    10 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 7/14/2021 - 3 years ago
    9 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 7/13/2021 - 3 years ago
    8 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 7/12/2021 - 3 years ago
    7 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 7/7/2021 - 3 years ago
    6 - ASSIGNED TO EXAMINER Type: DOCK
  • 6/28/2021 - 3 years ago
    5 - ASSIGNED TO EXAMINER Type: DOCK
  • 6/18/2021 - 3 years ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 3/12/2021 - 4 years ago
    3 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 3/8/2021 - 4 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS
  • 3/4/2021 - 4 years ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR